Fostamatinib disodium

How is Fostamatinib disodium dosed?

The typical oral dose of fostamatinib disodium for treating low platelet levels in patients with chronic immune thrombocytopenia is 100 milligrams (mg) taken twice a day. The dose may be adjusted by the doctor as necessary. This medication is not recommended for children. Follow your doctor's instructions or the label's directions. If you miss a dose, skip it and resume your regular dosing schedule. Do not take a double dose.

What is the dosage form of Fostamatinib disodium?

Fostamatinib disodium is available in the form of oral tablets.

What medications are contraindication with Fostamatinib disodium?

Fostamatinib disodium should only be taken under a doctor's prescription to treat low platelet levels in patients with chronic immune thrombocytopenia. It may cause side effects such as allergic reactions, nausea, diarrhea, stomach pain, headache, and unusual tiredness or weakness. It is important to inform your doctor about all the medications you are taking, including prescription, over-the-counter medicines, and any herbal or dietary supplements, to check for any potential interactions or contraindications.

How is Fostamatinib disodium administered?

Fostamatinib disodium is administered orally by taking tablets. The usual starting dose for adults is 100 milligrams (mg) taken twice a day. The dose may be adjusted by the doctor. This medication should not be used in children. Follow your doctor's instructions or the label's directions for the correct dosing schedule.

What are common precautions when taking Fostamatinib disodium?

When taking fostamatinib disodium, inform your doctor about any allergies you have, including allergies to foods, dyes, preservatives, or animals. Also, let your doctor know about any other medications you are currently taking, as there may be potential interactions. Caution is advised for elderly patients, as they may be more susceptible to serious side effects. This medication is not recommended for use in children, as its safety and efficacy have not been established in pediatric populations.